Is your melanoma hot enough for immunotherapy?
Source: Science Daily, May 2019 Melanomas tend to be “hot" or “cold" — if they’re hot, immunotherapy lights melanoma tumors like beacons for elimination by the immune system; but 40-50…
Read More Publications
Novel Immunotherapy Tebentafusp Granted Fast Track Designation for Metastatic Uveal Melanoma
Source: Targeted Oncology, May 2019 The FDA has granted tebentafusp (IMCgp100) a fast track designation for the treatment of patients with HLA-A*0201-positive previously untreated metastatic uveal melanoma, according to Immunocore…
Read More MRV Newletter Issue 10, May 2019
Please follow this link to download the 10th edition of the MRV newsletter.
Patterns of recurrence and retreatment outcomes among clinical stage I and II head and neck melanoma patients
Source: MDLinx, April 2019 Authors evaluated the survival outcomes in candidates who underwent retreatment of recurrent cutaneous melanoma of the head and neck between January 1, 2000, and December 31,…
Read More